Melanin-concentrating hormone receptor 1 antagonists for the treatment of depression and anxiety

Drug Development Research

Volumn 65, Issue 4, 2005, Pages 278-290

  Chaki, Shigeyuki ^a   Yamaguchi, Jun Ichi ^a   Yamada, Hisaharu ^a   Kanuma, Kosuke ^a   Sekiguchi, Yoshinori ^a  

^a TAISHO PHARMACEUTICAL CO LTD   (Japan)

Author keywords

Antidepressant; Anxiolytic; MCH; MCH1R; Melanin concentrating hormone

Indexed keywords

ANTIDEPRESSANT AGENT; ATC 0065; ATC 0175; BENZODIAZEPINE DERIVATIVE; CITALOPRAM; CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; CYCLIC AMP; DYNORPHIN; G PROTEIN COUPLED RECEPTOR; GONADORELIN; GONADOTROPIN; GW 3430; HORMONE RECEPTOR; HORMONE RECEPTOR BLOCKING AGENT; MELANIN CONCENTRATING HORMONE; MELANIN CONCENTRATING HORMONE RECEPTOR 1 ANTAGONIST; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; N (6 DIMETHYLAMINOMETHYL 5,6,7,8 TETRAHYDRO 2 NAPHTHYL) 4' FLUORO 1,1' BIPHENYL 4 CARBOXAMIDE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NEUROPEPTIDE; NEUROTRANSMITTER; OREXIN; PROTIRELIN; SEROTONIN UPTAKE INHIBITOR; SNAP 7941; THYROTROPIN; TRICYCLIC ANTIDEPRESSANT AGENT; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ANXIETY; CLINICAL TRIAL; DEPRESSION; EMOTION; ENERGY; FORCED SWIMMING TEST; HOMEOSTASIS; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; NONHUMAN; OBESITY; REVIEW; STRUCTURE ACTIVITY RELATION; TRANQUILIZING ACTIVITY;

EID: 29544442936     PISSN: 02724391     EISSN: None     Source Type: Journal    
DOI: 10.1002/ddr.20029     Document Type: Review

References (81)

1. American Psychiatric Association. 1994. Diagnostic and statistical manual of mental disorders, 4th edition. Washington, DC: American Psychiatric Press.
2. An S, Cutler G, Zhao JJ, Huang SG, Tian H, Li W, Liang L, Rich M, Bakleh A, Du J, Chen JL, Dai K. 2001. Identification and characterization of a melanin-concentrating hormone receptor. Proc Natl Acad Sci USA 98:7576-7581.
3. Bachner D, Kreienkamp H, Weise C, Buck F, Richter D. 1999. Identification of melanin concentrating hormone (MCH) as the natural ligand for the orphan somatostatin-like receptor 1 (SLC-I). FEBS Lett 457:522-524.
4. Banke TG, Bowie D, Lee H, Huganir RL, Schousboe A, Traynelis SF. 2000. Control of GluR1 AMPA receptor function by cAMP-dependent protein kinase. J Neurosci 20:89-102.
5. Bittencourt JC, Presse F, Arias C, Peto C, Vaughan J, Nahon JL, Vale W, Sawchenko PE. 1992. The melanin-concentrating hormone system of the rat brain: an immuno- and hybridization histochemical characterization. J Comp Neurol 319:218-245.
6. Borowsky B, Durkin MM, Ogozalek K, Marzabadi MR, DeLeon J, Lagu B, Henrich R, Lichtblau H, Shaposhnik Z, Daniewska I, Blackburn TP, Branchek TA, Gerald C, Vaysse PJ, Forray C. 2002. Antidepressant, anxiolytic and anorectic effects of a melanin-concentrating hormone-1 receptor antagonist. Nat Med 8:825-830.
7. Borsini F, Podhorna J, Marazziti D. 2002. Do animal models of anxiety predict anxiolytic-like effects of antidepressants? Psychopharmacology (Berl) 163:121-141.
8. Chaki S, Funakoshi T, Hirota-Okuno S, Nishiguchi M, Shimazaki T, Iijima M, Grottick AJ, Kamima K, Omodera K, Sekiguchi Y, Okuyama S, Tran TA, Semple G, Thomsen W. 2005. Anxiolytic- and antidepressant-like profile of ATC0065 and ATC0175: nonpeptidic and orally active melanin-concentrating hormone receptor 1 antagonists. J Pharmacol Exp Ther 313:831-839.
9. Chaki S, Nakazato A, Kennis L, Nakamura M, Mackie C, Sugiura M, Vinken P, Ashton D, Langlois X, Steckler T. 2004. Anxiolytic- and antidepressant-like profile of a new CRF1 receptor antagonist, R278995/CRA0450. Eur J Pharmacol 485:145-158.
10. Chambers J, Ames RS, Bergsma D, Muir A, Fitzgerald LR, Hervien G, Dytko GM, Foley JJ, Martin J, Lin WS, Park J, Ellis C, Ganguly S, Konchar S, Cluderay J, Leslie R, Wilson S, Saran HM. 1999. Melanin-concentrating hormone is the cognate ligand for the orphan G-protein-coupled receptor SLC-1. Nature 400:261-265.
11. Chefer VI, Czyzyk T, Bolan EA, Moron J, Pintar JE, Shippenberg TS. 2005. Endogenous kappa-opioid receptor systems regulate mesoaccumbal dopamine dynamics and vulnerability to cocaine. J Neurosci 25:5029-5037.
12. Chen Y, Hu C, Hsu CK, Zhang Q, Bi C, Asnicar M, Hsiung HM, Fox N, Slieker LJ, Yang DD, Heiman ML, Shi Y. 2002. Targeted disruption of the melanin-concentrating hormone receptor-1 results in hyperphagia and resistance to diet-induced obesity. Endocrinology 143:2469-2477.
13. Chiocchio SR, Gallardo MG, Louzan P, Gutnisky V, Tramezzani JH. 2001. Melanin-concentrating hormone stimulates the release of luteinizing hormone-releasing hormone and gonadotropins in the female rat acting at both median eminence and pituitary levels. Biol Reprod 64:1466-1472.
14. Collins CA, Kym PR. 2003. Prospects for obesity treatment: MCH receptor antagonists. Curr Opin Investig Drugs 4:386-394.
15. Cryan JF, Markou A, Lucki I. 2002. Assessing antidepressant activity in rodents: recent developments and future needs. Trends Pharmacol Sci 23:238-245.
16. David DJ, Saxe M, Craig D, Wolinsky T, Gerald C, Santarelli L, Hen R. 2004. Antidepressant-like effect of SNAP94847, a melanin concentrating hormone-1 receptor antagonist. 34th Society for Neuroscience Meeting: #356.1.
17. Duman RS, Nakagawa S, Malberg J. 2001. Regulation of adult neurogenesis by antidepressant treatment. Neuropsychopharmacology 25:836-844.
18. File SE, Seth P. 2003. A review of 25 years of the social interaction test. Eur J Pharmacol 463:35-53.
19. Fried S, O'Neill K, Hawes BE. 2002. Cloning and characterization of rhesus monkey MCH-R1 and MCH-R2. Peptides 23:1401-1408.
20. Georgescu D, Sears RM, Hommel JD, Barrot M, Bolanos CA, Marsh DJ, Bednarek MA, Bibb JA, Maratos-Flier E, Nestler EJ, DiLeone RJ. 2005. The hypothalamic neuropeptide melanin-concentrating hormone acts in the nucleus accumbens to modulate feeding behavior and forced-swim performance. J Neurosci 25:2933-2940.
21. Gonzalez MI, Vaziri S, Wilson CA. 1996. Behavioral effects of alpha-MSH and MCH after central administration in the female rat. Peptides 17:171-177.
22. Griebel G, Simiand J, Steinberg R, Jung M, Gully D, Roger P, Geslin M, Scatton B, Maffrand JP, Sonbrie P. 2002. 4-(2-Chloro-4-methoxy-5-methylphenyl)- N-[(1S)-2-cyclopropyl-1-(3-fluoro-4-methylphenyl) ethyl]5-methyl-N-(2-propynyl)- 1,3-thiazol-2-amine hydrochloride (SSR125543A), a potent and selective corticotrophin-releasing factor(1) receptor antagonist. II. Characterization in rodent models of stress-related disorders. J Pharmacol Exp Ther 301:333-345.
23. Handlon AL, Al-Barazanji KA, Barvian KK, Bigham EC, Carlton DL, Carpenter AJ, Cooper JP, Daniels AJ, Garrison DT, Goetz AS, Green GM, Grizzle MK, Guo YC, Hertzog DL, Hyman CE, Ignar DM, Peckham GE, Speake JD, Britt C, Swain WR. 2004. Discovery of potent and selective MCH receptor-1 antagonists for the treatment of obesity. 228th National Meeting of the American Chemistry Society: MED1193.
24. Hara J, Benekmann CT, Nambu T, Willie JT, Chemelli RM, Sinton CM, Sugiyama F, Yagami K, Goto K, Yanagisawa M, Sakurai T. 2001. Genetic ablation of orexin neurons in mice results in narcolepsy, hypophagia, and obesity. Neuron 30:345-354.
25. Harris AR, Fang SL, Azizi F, Lipworth L, Vagenakis AG, Barverman LE. 1978. Effect of starvation on hypothalamic-pituitary-thyroid function in the rat. Metabolism 27:1074-1083.
26. Hawes BE, Kil E, Green B, O'Neill K, Fried S, Graziano MP. 2000. The melanin-concentrating hormone receptor couples to multiple G proteins to activate diverse intracellular signaling pathways. Endocrinology 141:4524-4532.
27. Heinrichs SC, De Souza EB, Schulteis G, Lapsansky JL, Grigoriadis DE. 2002. Brain penetrance, receptor occupancy and antistress in vivo efficacy of a small molecule corticotropin releasing factor type I receptor selective antagonist. Neuropsychopharmacology 27:194-202.
28. Hervien GJ, Cluderay JE, Harrison D, Meakin J, Maycox P, Nasir S, Leslie RA. 2000. The distribution of the mRNA and protein products of the melanin-concentrating hormone (MCH) receptor gene, slc-1, in the central nervous system of the rat. Eur J Neurosci 12:1194-1216.
29. Hill J, Duckworth M, Murdock P, Rennie G, Sabido-David C, Ames RS, Szekeres P, Wilson S, Bergsma DJ, Gloger IS, Levy DS, Chambers JK, Muir AI. 2001. Molecular cloning and functional characterization of MCH2, a novel human MCH receptor. J Biol Chem 276:20125-20129.
30. Jezova D, Bartannsz V, Westergren I, Johansson BB, Rivier J, Vale W, Rivier C. 1992. Rat melanin-concentrating hormone stimulates adrenocorticotropin secretion: evidence for a site of action in brain regions protected by the blood-brain barrier. Endocrinology 130:1024-1029.
31. Kanuma K, Omodera K, Nishiguchi M, Funakoshi T, Chaki S, Semple G, Tran TA, Kramer B, Hsu D, Casper M, Thomsen B, Beeley N, Sekiguchi Y. 2005a. Discovery of 4-(dimethylamino)-quinazolines as potent and selective antagonists for the melanin-concentrating hormone receptor 1. Bioorg Med Chem Lett 15:2565-2569.
32. Kanuma K, Omodera K, Nishiguchi M, Funakoshi T, Chaki S, Semple G, Tran TA, Kramer B, Hsu D, Casper M, Thomsen B, Beeley N, Sekiguchi Y. 2005a. Lead optimization of 4-(dimethylamino)-quinazolines, potent and selective antagonists for the melanin-concentrating hormone receptor 1. Bioorg Med Chem Lett: 15:3853-3856.
33. Kawanchi H, Kawazoe I, Tsubokawa M, Kishida M, Baker BI. 1983. Characterization of melanin-concentrating hormone in chuni salmon pituitaries. Nature 305:321-323.
34. Kela J, Salmi P, Rimondini-Giorgini R, Heilig M, Wahlestedt C. 2003. Behavioural analysis of melanin-concentrating hormone in rats: evidence for orexigenic and anxiolytic properties. Regul Pept 114:109-114.
35. Kennedy AR, Todd JF, Dhillo WS, Seal LJ, Ghatei MA, O'Toole CP, Jones M, Witty D, Winborne K, Riley G, Hervieu G, Wilson S, Bloom SB. 2003. Effect of direct injection of melanin-concentrating hormone into the paraventricular nucleus: further evidence for a stimulatory role in the adrenal axis via SLC-1. J Neuroendocrinol 15:268-272.
36. Kennedy AR, Todd JF, Stanley SA, Abbott CR, Small CJ, Ghatei MA, Bloom SR. 2001. Melanin-concentrating hormone (MCH) suppresses thyroid stimulating hormone (TSH) release, in vivo and in vitro, via the hypothalamus and the pituitary. Endocrinology 142:3265-3268.
37. Knapp RJ, Goldenberg R, Shuck C, Cecil A, Watkins J, Miller C, Crites G, Malatynska E. 2002. Antidepressant activity of memory-enhancing drugs in the reduction of submissive behavior model. Eur J Pharmacol 440:27-35.
38. Knigge KM, Wagner JE. 1997. Melanin-concentrating hormone (MCH) involvement in pentylenetetrazole (PTZ)-induced seizure in rat and guinea pig. Peptides 18:1095-1097.
39. Kolakowski LF Jr, Jung BP, Niguyen T, Johnson MP, Lynch KR. Cheng R, Heng HH, George SR, O'Dowd BF. 1990. Characterisation of a human gene related to genes encoding somatostatin receptors. FEBS Lett 398:253-258.
40. Lembo PM, Grazzini E, Cao J, Hubatsch DA, Pelletier M, Hoffert C. St-Onge S, Pou C, Labrecqne J, Groblewski T, O'Dounell D, Payza K, Ahmad S, Walker P. 1999. The receptor for the orexigenic peptide melanin-concentrating hormone is a C-protein-coupled receptor. Nat Cell Biol 1:267-271.
41. Li X, Tixxano JP, Griffey K, Clay M, Lindstrom T, Skolniek P. 2001. Antidepressant-like actions of an AMPA receptor potentiator (LY39209S). Neuropharmacology 40:1028-1033.
42. Ludwig DS, Tritos NA, Mastaitis JW, Kulkarni R, Kokkoton E. Elmqnist J, Lowell R, Flier JS, Maratos-Flier E. 2001. Melanin-concentrating hormone overexpression in transgenic mice leads to obesity and insulin resistance. J Clin Invest 107:379-386.
43. Magne SD, Pliakas AM, Todtenkopf MS, Tomasiewicz HC, Zhang V, Stevens Jr WC, Jones RM, Portoghese PS, Carlezon Jr WA. 2003. Antidepressant-like effects of kappa-opioicl receptor antagonists in the forced swim test in rats. J Pharmacol Exp Ther 305:323-330.
44. Marsh DJ, Weingarth DT, Novi DE, Chen HY, Trumbaner ME, Chen AS, Ginan XM, Jiang MM, Feng Y, Camacho RE, Shen Z, Frazier EG, Yu H, Metzger JM, Kuca SJ, Shearman LP, Gopal-Truter S, MacNeil DJ, Strack AM, MacIntyre DE, Van der Ploeg LH, Qian S. 2002. Melanin-concentrating hormone 1 receptor-deficient mice are lean, hyperactive, and hyperphagic and have altered metabolism. Proc Natl Acad Sci USA 99:3240-3245.
45. McBriar MD, Guzik H, Xu R, Paruchova J, Li S, Palani A, Clader JW, Greenlee WJ, Hawes BE, Kowalski TJ, O'Neill K, Spar B, Weig B. 2005. Discovery of bicycloalkyl urea melanin concentrating hormone receptor antagonists: orally efficacious antiobesity therapeutics. J Med Chem 48:2274-2277.
46. Millan MJ, Brocco M, Gobert A, Dorey G, Casara P, Dekeyne A. 2001. Anxiolytic properties of the selective, non-peptidergic CRF(1) antagonists. CP154.526 and DMP695: a comparison to other classes of anxiolytic agent. Neuropsychopharmacology 25:585-600.
47. Monzon ME, De Barioglio SK. 1999. Response to novelty after i.e.v. injection of melanin-concentrating hormone (MCH) in rats. Physiol Behav 67:813-817.
48. Monzon ME, de Souza MM, Izquierdo LA, Izquierdo I, Barros DM, de Barioglio SR. 1999. Melanin-concentrating hormone (MCH) modifies memory retention in rats. Peptides 20:1517-1519.
49. Mori M, Harada M, Terao Y, Sugo T, Watanabe T, Shimomura Y, Abe M, Shintaui Y, Onda H, Nishimura O, Fujino M. 2001. Cloning of a novel G protein-coupled receptor, SLT, a subtype of the melanin-concentrating hormone receptor. Biochem Biophys Res Commun 283:1013-1018.
50. Mouri T, Takahashi K, Kawanchi H, Sone M, Totsune K, Murakami O, Itoi K, Olmeda M, Sasano H, Sasano N. 1993. Melanin-concentrating hormone in the human brain. Peptides 14:643-646.
51. Nahou JL, Presse F, Bittencourt JC, Sawchenko FE, Vale W. 1989. The rat melanin-concentrating hormone messenger ribonucleic acid encodes multiple putative neuropeptides coexpressed in the dorsolateral hypothalamus. Endocrinology 125:2056-2065.
52. Navarra P, Tsagarakis S, Coy DH, Rees LH, Besser GM, Grossman AB. 1990. Rat melanin concentrating hormone does not modify the release of CRH-41 from rat hypothalamus or ACTH from the anterior pituitary in vitro. J Endocrinol 127:R1-R4.
53. Nestler EJ, Barrot M, DiLeone RJ, Eisch AJ, Gold SJ, Monteggia LM. 2002. Neurobiology of depression. Neuron 34:13-25.
54. Njung'e K, Handley SL. 1991. Effects of 5-HT uptake inhibitors, agonists and antagonists on the burying of harmless objects by mice; a putative test for anxiolytic agents. Br J Pharmacol 104:105-112.
55. Pissios P, Maratos-Flier E. 2003. Melanin-concentrating hormone: from fish skin to skinny mammals. Trends Endocrinol Metab 14:243-248.
56. Pissios P, Trombly DJ, Tzameli I, Maratos-Flier E. 2003. Melanin-concentrating hormone receptor 1 activates extracellular signal-regulated kinase and synergizes with G(s)-coupled pathways. Endocrinology 144:3514-3523.
57. Presse F, Nahou JL, Fischer WH, Vale W. 1990. Structure of the human melanin concentrating hormone mRNA. Mol Endocrinol 4:632-637.
58. Qu D, Ludwig DS, Gammeltoft S, Piper M, Pelleymounter MA, Cullen MJ, Mathes WF, Przypek R, Kanarek R, Maratos-Flier E. 1996. A role for melanin-concentrating hormone in the central regulation of feeding behaviour. Nature 380:243-247.
59. Receveur JM, Bjurling E, Ulven T, Little PB, Norregaard PK, Hogberg T. 2004. 4-Acylamino- and 4-ureidoben/amides as melanin-concentrating hormone (MCH) receptor 1 antagonists. Bioorg Med Chem Lett 14:5075-5080.
60. Reeves DL, Levinson DM, Justesen DR, Lubiu B. 1985. Endogenous hyperthermia in normal human subjects: experimental study of emotional states (II). Int J Psychosom 32:18-23.
61. Risold PY, Fellmann D, Rivier J, Vale W, Bugnon C. 1992. Immunoreactivities for antisera to three putative neuropeptides of the rat melanin-concentrating hormone precursor are coexpressed in neurons of the rat lateral dorsal hypothalamus. Neurosci Lett 136:145-149.
62. Roy M, David N, Tian H, Giorgetti M. 2004. Genetic inactivation of melanin-concentrating hormone receptor 1 (MCHR1) in mice exerts anxiolytic and antidepressant-like effects. 34th Society for Neuroscience Meeting: #356.3
63. Sailer AW, Sano H, Zeng Z, McDonald TP, Pan J, Pong SS, Feighner SD, Tan CP, Fukami T, Iwaasa H, Hreniuk DL, Morin NR, Sadowski SJ, Ito M, Ito M, Bansal A, Ky B, Figneroa DJ, Jiang Q, Austin CP, MacNeil DJ, Ishihara A, Ihara M, Kanatani A, Van der Ploeg LH, Howard AD, Lin Q. 2001. Identification and characterization of a second melanin-concentrating hormone receptor, MCH-2R. Proc Natl Acad Sci USA 98:7564-7569.
64. Saito Y, Nothacker HP, Wang Z, Lin SH, Leslie F, Civelli O. 1999. Molecular characterization of the melanin-concentrating-hormone receptor. Nature 400:265-269.
65. Saito Y, Cheng M, Leslie FM, Civelli O. 2001. Expression of the melanin-concentrating hormone (MCH) receptor mRNA in the rat brain. J Comp Neurol 435:26-40.
66. Schatzberg AF. 2000. New indications for antidepressants. J Clin Psychiatry 61(Suppl 11):9-17.
67. Shimada M, Tritos NA, Lowell BB, Flier JS, Maratos-Flier E. 1998. Mice lacking melanin-concentrating hormone are hypophagic and lean. Nature 396:670-674.
68. Shimomura Y, Mori M, Sugo T, Ishibashi Y, Abe M, Kurokawa T, Onda H, Nishimura O, Sumino Y, Fujino M. 1999. Isolation and identification of melanin-concentrating hormone as the endogenous ligand of the SLC-1 receptor. Biochem Biophys Res Commun 261:622-626.
69. Shirayama Y, Ishida H, Iwata M, Hazama GI, Kawahara R, Duman RS. 2004. Stress increases dynorphin immunoreactivity in limbic brain regions and dynorphin antagonism produces antidepressant-like effects. J Neurochem 90:1258-1268.
70. Smith DG, Tzavara ET, Shaw J, Luecke S, Wade M, Davis H, Salhoff C, Nomikos GG, Geblert DR. 2005. Mesolimbic dopamine super-sensitivity in melanin-concentrating hormone-1 receptor-deficient mice. J Neurosci 25:914-922.
71. Soners AJ, Cao J, Wodka D, Judd AS, Mulhern MM, Napier JJ, Brune ME, Bush EN, Brodjian SJ, Dayton BD, Shapiro R, Hernandez LE, Marsh KC, Sham HL, Collins CA, Kyni PR. 2005. Synthesis and evaluation of urea-based indazoles as melanin-concentrating hormone receptor 1 antagonists for the treatment of obesity. Bioorg Med Chem Lett 15:2752-2757.
72. Spanagel R, Herz A, Shippenberg TS. 1992. Opposing tonically active endogenous opioid systems modulate the mesolimbic dopaminergic pathway. Proc Natl Acad Sci USA 89:2046-2050.
73. Spooren WP, Schoeffter P, Gasparini F, Kuhn R, Gentsch C. 2002. Pharmacological and endocrinological characterisation of stress-induced hyperthermia in singly housed mice using classical and candidate anxiolytics (LY314582, MPEP and NKP608). Eur J Pharmacol 435:161-170.
74. Svenningsson P, Tzavara ET, Witkin JM, Fienberg AA, Nomikos GG, Greengard P. 2002. Involvement of striatal and extrastriatal DARPP-32 in biochemical and behavioral effects of fluoxetine (Prozac). Proc Natl Acad Sci USA 99:3182-3187.
75. Takekawa S, Asami A, Ishihara Y, Terauchi J, Kato K, Shimomura Y, Mori M, Murakoshi H, Kato K, Suzuki N, Nishimura O, Fujino M. 2002. T-226296: A novel, orally active and selective melanin-concentrating hormone receptor antagonist. Eur J Pharmacol 438:129-135.
76. Tan CP, Sano H, Iwaasa H, Pan J, Sailer AW, Hreniuk DL, Feighner SD, Palyha OC, Pong SS, Figueroa DJ, Austin CP, Jiang MM, Yu H, Ito J, Ito M, Ito M, Guan XM, MacNeil DJ, Kanatani A, Van der Ploeg LH, Howard AD. 2002. Melanin-concentrating hormone receptor subtypes 1 and 2: species-specific gene expression. Genomics 79:785-792.
77. Varas MM, Perez MF, Ramirez, OA, de Barioglio SR. 2003. Increased susceptibility to LTP generation and changes in NMDA-NR1 and -NR2B subunits mRNA expression in rat hippocampus after MCH administration. Peptides 24:1403-1411.
78. Vaughan JM, Fischer WH, Hoeger C, Rivier J, Vale W. 1989. Characterization of melanin-concentrating hormone from rat hypothalamus. Endocrinology 125:1660-1665.
79. Verret L, Gontagny R, Fort P, Cagnon L, Salvert D, Leger L, Boissard H, Salin P, Pevron C, Luppi PH. 2003. A role of melanin-concentrating hormone producing neurons in the central regulation of paradoxical sleep. BMC Neurosci 4:19.
80. Willner P, Muscat H, Papp M. 1992. Chronic mild stress-induced anhedonia: a realistic animal model of depression. Neurosci Biobehav Rev 16:525-534.
81. Wolinsky TD, Craig DA, Patel J, Lichtblan H, Papp M, Gerald CP. 2004. Anxiolytic and antidepressant-like activity of SNAP94847, a novel MCH-1 antagonist. 34th Society for Neuroscience Meeting: #356.14.